Subscribe for Updates

Congrats! You’re subscribed

Chiesi Ventures invest in Minoryx

October 14, 2015

Chiesi Ventures invest in rare CNS disease company Minoryx. Minoryx is based in Barcelona, Spain and is developing treatments for X-linked adrenoleukodystrophy and other rare CNS disorders.

Minoryx Therapeutics complete Series A funding of €19.4M ($21.7M)

October 14, 2015

Funds will help company reach clinical validation for lead candidate in X-ALD, a rare neurodegenerative and life-threatening disease